Quackenbush-Baker v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided December 14, 2016·No. 14-1000·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-1000V Filed: October 26, 2016

* * * * * * * * * * * * * UNPUBLISHED ERIN QUACKENBUSH-BAKER, * * Special Master Gowen Petitioner, * * Interim Attorneys’ Fees and Costs v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * Curtis R. Webb, Twin Falls, ID, for petitioner. Christine M. Becer, United States Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS' FEES AND COSTS1

On October 16, 2014, Erin Quackenbush-Baker (“petitioner”) filed a petition pursuant to the National Vaccine Injury Compensation Program.2 Petitioner alleged that as a result of receiving a trivalent influenza (“flu”) vaccination on November 20, 2013, she experienced a significant aggravation of a preexisting, but asymptomatic, multiple sclerosis. See Petition at ¶¶1-2. The parties have submitted expert reports and an entitlement hearing is scheduled for February 2-3, 2017.

1 Because this decision contains a reasoned explanation for the undersigned’s action in this case, the undersigned intends to post this ruling on the website of the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012)(Federal Management and Promotion of Electronic Government Services). As provided by Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b).

2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to 34 (2012) (“Vaccine Act” or “the Act”). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.

1 On April 5, 2016, petitioner filed a motion for interim attorneys’ fees and costs, requesting $95,204.50 in attorneys’ fees and $11,990.56 in attorneys’ costs, for a total of $107,195.06 in attorneys’ fees and costs. Petitioner’s (“Pet.”) Motion (“Mot.”) at 1-2. In accordance with General Order #9, petitioner states that she did not incur any costs in the prosecution of this matter. Pet. General Order #9 Statement. Respondent filed a response to petitioner’s motion on April 21, 2016, stating that respondent “defers to the special master to determine whether or not petitioner has met the legal standard for an interim fees and costs award.” Respondent’s (“Resp.”) Response at 2. Respondent states that:

Should the Special Master conclude that an award of interim fees and costs is appropriate, respondent asserts that, based on a survey of interim fee awards in other cases and her experience litigating Vaccine Act claims, a total reasonable amount for fees and costs in the present case, given its procedural posture, would fall between $35,000.00 and $40,000.00.

Resp. Response at 3 (internal footnote and citations omitted). Respondent therefore “requests that the special master reduce petitioner’s fees and costs in accordance with the law and exercise his discretion to otherwise determine a reasonable award for attorneys’ fees and costs within the range proposed by respondent.” Id. at 4. Petitioner filed a reply on April 28, 2016. This matter is now ripe for adjudication.

I. Interim Attorneys’ Fees and Costs

The Vaccine Act permits an award of reasonable attorneys’ fees and costs under 42 U.S.C. section 300aa-15(e). In addition, interim attorneys’ fees and costs are permissible under the Vaccine Act. See Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008); see also Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010). When a petitioner has yet to prove entitlement, a special master “may award an amount of compensation” for reasonable attorneys’ fees and costs “if the special master . . . determines that the petition was brought in good faith and there was a reasonable basis for the claim.” 42 U.S.C. § 300aa-15(e)(1)(B); Sebelius v. Cloer, 133 S. Ct. 1886, 1893 (2013). While respondent defers to the special master regarding whether an award of interim fees is appropriate in this case, respondent otherwise “is satisfied that the statutory and other legal requirements for an award of attorneys’ fees and costs are met,” and the undersigned finds that the claim was brought in good faith and with a reasonable basis. Resp. Response at 2.

In Avera, the Federal Circuit stated that “[i]nterim fees are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” 515 F.3d at 1352. In Shaw, the Federal Circuit held that “where the claimant establishes that the cost of litigation has imposed an undue hardship and there exists a good faith basis for the claim, it is proper for the special master to award interim attorneys' fees.” 609 F.3d at 1375. This case was filed October 16, 2014, two years ago. Because of constraints on the undersigned’s time due to the volume of petitions currently in the Program, the entitlement hearing will not occur until February 2017, another three months from present. The issuance of an entitlement decision following hearing will likely take several months more, after which this case will still need to

2 proceed through the damages phase, which could take significant time in and of itself. Petitioner in this case has obtained four expert reports from Dr. Lawrence Steinman, and has retained him for hearing. Because of the protracted nature of the proceedings to date, the fact that costly expert reports have been obtained, and the fact that the ultimate resolution of the case will not occur for a significant time, the undersigned finds an award of interim attorneys’ fees and costs appropriate at this time.

II. Reasonable Attorneys’ Fees and Costs

The Federal Circuit has approved use of the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera, 515 F.3d at 1349. Using the lodestar approach, a court first determines “an initial estimate of a reasonable attorneys’ fee by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. at 1347-58 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). Then, the court may make an upward or downward departure from the initial calculation of the fee award based on other specific findings. Id. at 1348. The determination of reasonable attorneys’ fees and costs is within the special master's discretion. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1520 (Fed. Cir. 1993). Special masters may rely on their prior experience in reviewing fee applications.

Free access — add to your briefcase to read the full text and ask questions with AI

Quackenbush-Baker v. Secretary of Health and Human Services, (uscfc 2016).

Quackenbush-Baker v. Secretary of Health and Human Services (Quackenbush-Baker v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Avera v. Secretary of Health and Human Services
515 F.3d 1343 (Federal Circuit, 2008)
Sebelius v. Cloer
133 S. Ct. 1886 (Supreme Court, 2013)
Shaw v. Secretary of Health and Human Services
609 F.3d 1372 (Federal Circuit, 2010)
Savin v. Secretary of Health & Human Services
85 Fed. Cl. 313 (Federal Claims, 2008)
Garrison v. Secretary of Health & Human Services
128 Fed. Cl. 99 (Federal Claims, 2016)